Señales en vivo de ALLR | Maximiza tus Ganancias con Getagraph.com

Live Chart Being Loaded With Signals

Commentary (20 may 2024 @ 16:00):

Stats
Volumen de hoy	4.36M
Volumen promedio	3.34M
Capitalización de mercado	11.05M
EPS	$0 ( 2024-05-09 )
Próxima fecha de ganancias	( $0 ) 2024-08-12
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	0
ATR14	$0.00100 (0.16%)

Insider Trading

Date	Person	Action	Amount	type
2023-08-01	Benjamin Laura	Buy	0
2023-08-01	Vazzano Joseph Walter	Buy	0
2021-12-20	Carchedi Steve	Sell	70 477	Stock Options
2021-12-20	Carchedi Steve	Sell	156 025	Stock Options
2021-12-20	Carchedi Steve	Sell	252 555	Stock Options

INSIDER POWER
0.00
Last 5 transactions
Buy: 0 \| Sell: 505 299

Volumen Correlación

Largo: 0.03 (neutral)

Corto: 0.34 (neutral)

Signal:(55.149) Neutral

Allarity Therapeutics, Correlación

10 Correlaciones Más Positivas
JACK	0.978
APVO	0.974
LULU	0.971
EZGO	0.963
CMTL	0.961
VEEE	0.96
HAIN	0.96
SIRI	0.957
OSUR	0.957
SRNE	0.954

10 Correlaciones Más Negativas
IVCB	-0.982
BCSA	-0.966
NKTR	-0.961
PAYS	-0.958
GDST	-0.958
SWAV	-0.958
KEQU	-0.953
NSYS	-0.951
LABP	-0.951
ENTX	-0.946

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Allarity Therapeutics, Correlación - Moneda/Commodity

-0.53
( weak negative )

0.00
( neutral )

0.63
( weak )

Allarity Therapeutics, Finanzas

Annual	2023
Ingresos:	$0
Beneficio Bruto:	$-37 000.00 (0.00 %)
EPS:	$-5.98

FY	2023
Ingresos:	$0
Beneficio Bruto:	$-37 000.00 (0.00 %)
EPS:	$-5.98

FY	2022
Ingresos:	$0
Beneficio Bruto:	$-120 000 (0.00 %)
EPS:	$-2 359.71

FY	2021
Ingresos:	$0.00
Beneficio Bruto:	$0.00 (0.00 %)
EPS:	$-0.630

Financial Reports:

No articles found.

Allarity Therapeutics, Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Allarity Therapeutics,

Allarity Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing oncology therapeutics using drug-specific companion diagnostics generated by its drug response predictor technology. Its drug candidates include Stenoparib, a poly-ADP-ribose polymerase inhibitor that is in Phase 2 clinical trials for ovarian cancer; Dovitinib, a pan- tyrosine kinase inhibitor for the treatment of renal cell carcinoma; IXEMPRA, a microtubule inhibitor for the treatment of metastatic breast cancer; LiPlaCis, a liposomal formulation of cisplatin, which is in Phase 2 clinical trials for metastatic breast cancer; and 2X-111, a liposomal formulation of doxorubicin that is in Phase 2 clinical trials for metastatic breast cancer and glioblastoma multiforme. The company was incorporated in 2004 and is headquartered in Cambridge, Massachusetts.